Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report

INTRODUCTION: Patients who receive or have received anti-programmed cell-death-1 (PD-1) monoclonal antibodies can develop immune-related adverse events due to activation of the immune system. CASE PRESENTATION: We report a case of a patient who received pembrolizumab and presented with cardiac tampo...

Descripción completa

Detalles Bibliográficos
Autores principales: Oristrell, Gerard, Bañeras, Jordi, Ros, Javier, Muñoz, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177032/
https://www.ncbi.nlm.nih.gov/pubmed/31020118
http://dx.doi.org/10.1093/ehjcr/yty038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177032/
https://www.ncbi.nlm.nih.gov/pubmed/31020118
http://dx.doi.org/10.1093/ehjcr/yty038

Ejemplares similares